Literature DB >> 22216511

Correlation of pupil reactivity to tyramine or hydroxyamphetamine and tyramine pressor responses in patients treated with amitriptyline or mianserin.

K Ghose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216511      PMCID: PMC1428898          DOI: 10.1111/j.1365-2125.1976.tb04892.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

2.  Pupil responsiveness to tyramine in depressed patients treated with amitriptyline.

Authors:  E Szabadi; J Besson; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

3.  Recent studies on the mode of action of antidepressive drugs.

Authors:  A Carlsson
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

4.  Intravenous tyramine pressor response in depression.

Authors:  K Ghose; P Turner
Journal:  Lancet       Date:  1975-06-14       Impact factor: 79.321

5.  The human pupil as a model for clinical pharmacological investigations.

Authors:  P Turner
Journal:  J R Coll Physicians Lond       Date:  1975-01
  5 in total
  3 in total

1.  Assessment of Peripheral adrenergic activity and its interactions with drugs in man.

Authors:  K Ghose
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

2.  Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo.

Authors:  E Szabadi; P Gaszner; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Decreased tyramine sensitivity after discontinuation of amitriptyline therapy. An index of pharmacodynamic half-life.

Authors:  K Ghose
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.